Sporck Alistair N: insider trades.
Sporck Alistair N reported 10 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($310K), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- SPORCK ALISTAIR N
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Aehr Test Systems (AEHR) | Officer · VP Contactor Business Unit | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Aehr Test Systems | S | 1,000 | $108.49 | 22,547 | Form 4 |
| 2026-08-04 | Aehr Test Systems | S | 1,301 | $101.1 | 23,547 | Form 4 |
| 2026-08-04 | Aehr Test Systems | S | 699 | $100.7 | 24,848 | Form 4 |
| 2026-07-27 | Aehr Test Systems | F | 133 | $77.48 | 25,547 | Form 4 |
| 2026-07-20 | Aehr Test Systems | F | 334 | $81.05 | 25,680 | Form 4 |
| 2026-07-13 | Aehr Test Systems | F | 209 | $72.6 | 26,014 | Form 4 |
| 2026-07-02 | Aehr Test Systems | F | 259 | $69.96 | 26,223 | Form 4 |
| 2026-07-01 | Aehr Test Systems | A | 6,165 | $0 | 26,326 | Form 4 |
| 2026-07-01 | Aehr Test Systems | A | 2,369 | $0 | 28,695 | Form 4 |
| 2026-07-01 | Aehr Test Systems | F | 2,213 | $84.43 | 26,482 | Form 4 |
Questions
What stock did Sporck Alistair N buy or sell?
Sporck Alistair N reported 10 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($310K), across 1 company.
Is Sporck Alistair N the same person as other filers with this name?
This page covers SEC CIK 1939261 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/sporck-alistair-n-1939261.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.